safe: cardioprotective strategy for non-metastatic bc patients receiving anthracycline-based chemo
Published 2 years ago • 75 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
1:47
safe: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab
-
1:57
cardioprotective strategies in the management of breast cancer
-
20:56
cardiovascular recovery in anthracycline cardiotoxicity
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
1:01
patients ask me - what is a subcutaneous implantable cardiac defibrillator (s-icd)?
-
0:55
an invisible system to rescue the heart
-
3:03
medication harm in patients after acute myocardial infarction
-
0:56
cied: what are the risk factors?
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
7:50
implantable defibrillator a common treatment option for sudden cardiac death
-
1:22
large infarct size increases risk of heart attack
-
1:19
#tomorrowsdiscoveries: preventing heart failure – david kass, m.d.
-
20:20
challenging cases in nafld and nash: diagnosis
-
0:33
tell me more: implantable cardioverter defibrillators
-
6:30
ehra 2021: long-term efficacy and outcomes of the s-icd registry
-
1:02
absorbable antibiotic envelope can cut cardiac device infections
-
3:22
implantable cardioverter defibrillators
-
2:16
adverse effects and braf inhibitors in mnsclc